Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
- Conditions
- Interventions
- First Posted Date
- 2006-09-21
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 395
- Registration Number
- NCT00379340
- Locations
- πΊπΈ
Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
πΊπΈLurie Children's Hospital-Chicago, Chicago, Illinois, United States
πΊπΈRainbow Babies and Childrens Hospital, Cleveland, Ohio, United States
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2006-09-07
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 74
- Registration Number
- NCT00372619
- Locations
- π¨π¦
Hospital for Sick Children, Toronto, Ontario, Canada
πΊπΈCCOP - Nevada Cancer Research Foundation, Las Vegas, Nevada, United States
πΊπΈMasonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
- Conditions
- Interventions
- First Posted Date
- 2006-09-07
- Last Posted Date
- 2021-03-24
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 1070
- Registration Number
- NCT00372593
- Locations
- πΊπΈ
University of Illinois Cancer Center, Chicago, Illinois, United States
πΊπΈChildrens Hospital Los Angeles, Los Angeles, California, United States
πΊπΈArkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Conditions
- Childhood Acute Erythroleukemia (M6)Childhood Acute Megakaryocytic Leukemia (M7)Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)Childhood Acute Basophilic LeukemiaChildhood Acute Myeloblastic Leukemia With Maturation (M2)Childhood Acute Eosinophilic LeukemiaChildhood Acute Monocytic Leukemia (M5b)Childhood Acute Myelomonocytic Leukemia (M4)Childhood Myelodysplastic Syndromesde Novo Myelodysplastic Syndromes
- Interventions
- First Posted Date
- 2006-08-29
- Last Posted Date
- 2022-01-28
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 205
- Registration Number
- NCT00369317
- Locations
- πΊπΈ
Nationwide Children's Hospital, Columbus, Ohio, United States
πΊπΈJohns Hopkins University-Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
π¨π¦Hospital for Sick Children, Toronto, Ontario, Canada
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
- Conditions
- Adult RhabdomyosarcomaChildhood Botryoid-Type Embryonal RhabdomyosarcomaRhabdomyosarcomaSarcomaStage I Adult Soft Tissue Sarcoma AJCC v7Stage III Adult Soft Tissue Sarcoma AJCC v7Localized Childhood Soft Tissue SarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal RhabdomyosarcomaStage II Adult Soft Tissue Sarcoma AJCC v7
- Interventions
- First Posted Date
- 2006-07-20
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 481
- Registration Number
- NCT00354835
- Locations
- πΊπΈ
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
πΊπΈSinai Hospital of Baltimore, Baltimore, Maryland, United States
πΊπΈKaiser Permanente Downey Medical Center, Downey, California, United States
High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
- First Posted Date
- 2006-07-20
- Last Posted Date
- 2020-01-29
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 109
- Registration Number
- NCT00354744
- Locations
- πΊπΈ
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States
πΊπΈNemours Children's Clinic, Jacksonville, Florida, United States
πΊπΈCarole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center, Farmington, Connecticut, United States
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
- Conditions
- Interventions
- Radiation: 3-Dimensional Conformal Radiation TherapyProcedure: Biospecimen CollectionProcedure: Chest RadiographyProcedure: Computed TomographyBiological: DactinomycinDrug: Doxorubicin HydrochlorideProcedure: EchocardiographyProcedure: Magnetic Resonance ImagingProcedure: Therapeutic Conventional SurgeryProcedure: Ultrasound ImagingDrug: Vincristine Sulfate
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 808
- Registration Number
- NCT00352534
- Locations
- πΊπΈ
University of Connecticut, Farmington, Connecticut, United States
πΊπΈSinai Hospital of Baltimore, Baltimore, Maryland, United States
πΊπΈSaint Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
- Conditions
- Interventions
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 26
- Registration Number
- NCT00352495
- Locations
- πΊπΈ
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States
πΊπΈSUNY Upstate Medical University Hospital, Syracuse, New York, United States
πΊπΈChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
- Conditions
- Adult Extraskeletal OsteosarcomaAdult Malignant Fibrous HistiocytomaChildhood FibrosarcomaChildhood LiposarcomaMetastatic Childhood Soft Tissue SarcomaNonmetastatic Childhood Soft Tissue SarcomaStage I Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma
- Interventions
- First Posted Date
- 2006-06-29
- Last Posted Date
- 2022-04-28
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 588
- Registration Number
- NCT00346164
- Locations
- πΊπΈ
Driscoll Children's Hospital, Corpus Christi, Texas, United States
πΊπΈNew York Medical College, Valhalla, New York, United States
πΊπΈChildren's Hospital Central California, Madera, California, United States
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
- Conditions
- Interventions
- Procedure: Autologous Hematopoietic Stem Cell TransplantationDrug: CarboplatinDrug: CisplatinDrug: CyclophosphamideDrug: EtoposideBiological: FilgrastimOther: Laboratory Biomarker AnalysisOther: Quality-of-Life AssessmentDrug: Leucovorin CalciumDrug: ThiotepaDrug: MethotrexateDrug: Vincristine Sulfate
- First Posted Date
- 2006-06-12
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 91
- Registration Number
- NCT00336024
- Locations
- πΊπΈ
Tulane University School of Medicine, New Orleans, Louisiana, United States
πΊπΈCorewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States
πΊπΈNYU Langone Hospital - Long Island, Mineola, New York, United States